HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC-L’Oreal Settlement Should Reverberate Across Industry – Attorneys

This article was originally published in The Rose Sheet

Executive Summary

The recent action against L’Oreal sends a signal to industry that FTC is paying attention to their claims. In an interview with “The Rose Sheet,” attorneys from Edwards Wildman Palmer discuss the case’s implications and whether it heralds a new FTC focus on cosmetics.

Advertisement

Related Content

NuGene Growing Its Stem-Cell Cosmeceuticals Biz; Regulatory Risks Noted
Audio Feature: FDA Monitoring Cosmetic Claims, But Litigation Remains Biggest Threat
Are Beauty Ads Held To Unique Standards? NARB Ruling Spurs Debate
FTC-L’Oreal Settlement Will Fuel Cosmetics Class Actions – Attorney
FTC Fines L’Occitane For “Slimming” Claims, Calls For Media “Gut Check”
FDA Warns Lancome For Gene/Stem-Cell Claims: A Signal To Marketplace?

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS019105

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel